KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,526,000 | -41.1% | 214,898 | +27.5% | 0.20% | -58.7% |
| Q2 2014 | $2,592,000 | -34.1% | 168,513 | -27.0% | 0.49% | -30.6% |
| Q1 2014 | $3,933,000 | +25.0% | 230,784 | -5.0% | 0.71% | +25.9% |
| Q4 2013 | $3,146,000 | +34.3% | 242,915 | +4.8% | 0.56% | +20.6% |
| Q3 2013 | $2,342,000 | +29.0% | 231,899 | -4.6% | 0.47% | +18.5% |
| Q2 2013 | $1,816,000 | – | 243,129 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |